Search results for " TREATMENT"

showing 10 items of 3424 documents

Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell L…

2022

Background: Despite the increasing implementation of targeted and immunotherapy-based treatments, the prognosis of patients with advanced NSCLC remains dismal. We prospectively evaluated longitudinal plasma cfDNA kinetics as an early marker of therapeutic efficacy in patients with advanced NSCLC undergoing standard first-line treatments. Methods: From February 2020 to May 2022, treatment-naïve patients with advanced NSCLC were consecutively enrolled at the Medical Oncology Unit of the Paolo Giaccone University Hospital, Palermo (Italy). We quantified cfDNA in terms of ng/μL using a QubitTM dsDNA HS Assay Kit. The agreement between the cfDNA and radiologic response was evaluated from…

treatment monitoringCancer Researchliquid biopsyOncologyECOG-PS 2cfDNANSCLCNSCLC; liquid biopsy; cfDNA; treatment monitoring; ECOG-PS 2Cancers
researchProduct

Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial

2022

Background and purpose: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with limited treatment options. RNS60 is an immunomodulatory and neuroprotective investigational product that has shown efficacy in animal models of ALS and other neurodegenerative diseases. Its administration has been safe and well tolerated in ALS subjects in previous early phase trials. Methods: This was a phase II, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial. Participants diagnosed with definite, probable or probable laboratory-supported ALS were assigned to receive RNS60 or placebo administered for 24 weeks intravenously (375 ml) once a week and via nebul…

treatmentAmyotrophic Lateral Sclerosisplacebo-controlledNeurodegenerative DiseasesALS; clinical trial; placebo-controlled; randomized; treatmentclinical trialTreatment OutcomeNeurologyDouble-Blind MethodrandomizedQuality of LifeHumansSettore MED/26 - NeurologiaNeurology (clinical)ALSBiomarkers
researchProduct

Types, triggers and treatment strategies of psoriasis

2013

Psoriasis is a common chronic, immune mediated, inflammatory disease,characterized by periods of exacerbation and remission. Patients with psoriasis have asignificantly impaired quality of life; the disease is associated with substantial burden interms of disability or psychosocial stigmatization. Moreover, in a percentage of patientsthat varies between 5% and 42%, depending on the population studied, psoriatic arthritismay occur.Psoriasis is found worldwide but the prevalence varies among different ethnicgroups. It has a strong genetic component but environmental factors such as ß-haemolyticstreptococcal infection, HIV, stress, and drugs, including ß blockers, antimalarials andlithium can …

triggers treatmentpsoriasis
researchProduct

Real-world experience with obeticholic acid in patients with primary biliary cholangitis

2021

Background & aims Obeticholic acid (OCA) is the second-line treatment approved for patients with primary biliary cholangitis (PBC) and an inadequate response or intolerance to ursodeoxycholic acid. We aimed to evaluate the effectiveness and safety of OCA under real-world conditions. Methods Patients were recruited into the Italian PBC Registry, a multicentre, observational cohort study that monitors patients with PBC at national level. The primary endpoint was the biochemical response according to Poise criteria; the secondary endpoint was the biochemical response according to normal range criteria, defined as normal levels of bilirubin, alkaline phosphatase (ALP), and alanine aminotransfer…

upper limit of normalCirrhosisALTAMAAutoimmunityantinuclear antibodiesULNPBCGastroenterologyUDCASettore MED/12ULN upper limit of normalobeticholic acidaRR adjusted risk ratio.CRFs case record formAST aspartate transferaseClinical endpointGGT gamma-glutamyl transferaseQCprimary biliary cholangitisGastroenterologyUrsodeoxycholic acidANATCCCirrhosisCholestasiTIPSTreatment Completer CohortANA antinuclear antibodiemedicine.medical_specialtyRRUDCA ursodeoxycholic acidTIPS transjugular intrahepatic portosystemic shuntOCACirrhosiALP alkaline phosphataseautoimmune hepatitismedicine.diseasedigestive system diseasesDiscontinuationKeywords: AIH autoimmune hepatitiQC quality controlchemistrygamma-glutamyl transferaserandomised controlled trialelectronic data captureantimitochondrial antibodiesaspartate transferaseAutoimmune hepatitischemistry.chemical_compoundAIHCRFsImmunology and Allergyadjusted risk ratioANA antinuclear antibodiesRR risk ratioOverall cohortALT alanine transferaseAMA antimitochondrial antibodieCholestasisCRFs case record formsObeticholic acidOverlap PBC-AIHursodeoxycholic acidOCA obeticholic acidTolerabilityalkaline phosphataseRCTResearch Articlemedicine.drugcase record formsContext (language use)AMA antimitochondrial antibodiesInternal medicineEDC electronic data capturetransjugular intrahepatic portosystemic shuntInternal MedicinemedicineRCT randomised controlled trialaRR adjusted risk ratioOClcsh:RC799-869quality controlalanine transferaseASTaRRHepatologybusiness.industryAutoimmunity; Cholestasis; Cirrhosis; Overlap PBC-AIHAIH autoimmune hepatitisTCC Treatment Completer CohortPBC primary biliary cholangitiGGTrisk ratioOC Overall cohortALPlcsh:Diseases of the digestive system. GastroenterologyPBC primary biliary cholangitisbusinessEDC
researchProduct

Noninvasive neurostimulation methods for migraine therapy: The available evidence.

2016

Background Migraine is one of the most disabling neurological disorders. The current pharmacological armamentarium is not satisfying for a large proportion of patients because the responder rate does not exceed 50% on average and the most effective drugs often induce intolerable side effects. During recent years, noninvasive central and peripheral neuromodulation methods have been explored for migraine treatment. Overview A review of the available evidence suggests that noninvasive neuromodulation techniques could be beneficial for migraine patients. The transcranial stimulation methods allow modulating selectively cortical activity and can thus be curtailed to the patient’s pathophysiologi…

vagus nervesneurology (clinical)orbital stimulationmedicine.medical_specialtymedicine.medical_treatmentMigraine DisordersTranscranial Direct Current Stimulation03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationmedicineHumans030212 general & internal medicineMigraine treatmentDeep transcranial magnetic stimulationNeurostimulationtranscranial direct current stimulation; transcranial magnetic stimulation; transcutaneous suprave stimulation; evidence-based medicine; humans; migraine disorders; transcranial direct current stimulation; transcranial magnetic stimulation; transcutaneous electric nerve stimulation; treatment outcome; neurology (clinical)orbital stimulation; vagus nervesEvidence-Based MedicineTranscranial direct-current stimulationbusiness.industryGeneral Medicinemedicine.diseaseTranscranial Magnetic StimulationNeuromodulation (medicine)Transcranial magnetic stimulationTreatment OutcomeMigraineAnesthesiaTranscutaneous Electric Nerve StimulationNeurology (clinical)business030217 neurology & neurosurgeryVagus nerve stimulationtranscutaneous suprave stimulationCephalalgia : an international journal of headache
researchProduct

Impact assessment of a solar powered water treatment project

2015

Water treatment technologies are seen as the best alternative to be considered for adoption in developing countries where access to portable water supply that is free of pathogens is yet a challenge. This study intended to assess impact brought forth by a project, which employed a water treatment technology in rural settings of Morogoro Region in Tanzania. The project used solar photovoltaic panels to trap solar energy, converted to mechanical power to treat water with the help of sterilization ultraviolet membrane. A comparative analysis was used as an assessment framework to study impacts of the project with respect to the quality of approach used during the project life cycle. Determinan…

vaikutuksetUV membraneSolar EnergyAssessmentaurinkoenergiavedenkäsittelyarviointiWater Treatment System
researchProduct

Vascularized lymph node transfer for treatment of extremity lymphedema: An overview of current controversies regarding donor sites, recipient sites a…

2018

As lymphatic microsurgery has become more common, vascularized lymph node transfer ascended to the forefront in many centers for the surgical management of advanced stages of lymphedema showing substantial clinical improvement. However, no consensus has been reached among experts regarding many details of the procedures, including patient selection criteria, type of treatment, donor, and recipient sites and postoperative evaluation of the outcome. Here, we will review these issues and provide the current results of this procedure.

vascularized lymph node transfer lymphedema lymphatic microsurgerymedicine.medical_specialtymedicine.medical_treatmentTreatment outcome030230 surgery03 medical and health sciences0302 clinical medicinemedicineHumansLymphedemaLymph nodebusiness.industryGeneral surgeryAdvanced stageExtremitiesGeneral MedicineMicrosurgerymedicine.diseaselymphatic microsurgery; lymphedema; vascularized lymph node transfer; Humans; Lymph Nodes; Lymphedema; Treatment Outcome; ExtremitiesLymphatic systemLymphedemamedicine.anatomical_structureTreatment OutcomeOncology030220 oncology & carcinogenesisSurgeryLymph NodesbusinessJournal of surgical oncology
researchProduct

Environmental remediation using nanomaterial as adsorbents for emerging micropollutants

2023

Water shortage and scarcity are issues of global concern. Water pollution caused by organic micropollutants further aggravates the problem, by rendering an already scarce resource unfit for human consumption. The existing conventional wastewater treatment methods and infrastructure were not designed to eliminate micropollutants. Therefore, their inefficiencies call for modern methods for removing emerging micropollutant residues such as Active Pharmaceutical Ingredients (APIs), Endocrine Disrupting Compounds (EDCs), personal care products and pesticides. The use of nanomaterials, for the abatement of micropollutants in water is gaining traction in recent years, due to the abundance of susta…

vedenpuhdistusMaterials Science (miscellaneous)antibiootittorjunta-aineetpesticidesjätevesiManagement Monitoring Policy and LawmicropollutantsPollutionantibioticswastewater treatment methodsmikrosaasteetnanoparticlesnanohiukkasetsteroiditwastewaterWaste Management and Disposalsteroidsenvironmental remediationjäteveden käsittelyWater Science and TechnologyEnvironmental Nanotechnology, Monitoring & Management
researchProduct

Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus

2019

Background. Management of venous thromboembolism (VTE) in patients with haematologic malignancies and thrombocytopenia is clinically challenging due to the related risks. No prospective studies or clinical trials have been carried out and, therefore, no solid evidence on this compelling issue is available. Methods. Given this, an expert panel endorsed by the Gruppo Italiano Malattie Ematologiche dell'Adulto Working Party on Thrombosis and Haemostasis was set up to produce a formal consensus, according to the RAND method, in order to issue clinical recommendations about the platelet (PLT) cut-off for safe administration of low molecular weight heparin (LMWH) in thrombocytopenic (PLT <100×…

venous thrombosis thrombocytopenia blood cancer anticoagulant treatment consensusanticoagulantsblood cancerblood plateletsvenous thromboembolismthrombocytopeniaHeparin Low-Molecular-Weightheparinplatelet countanticoagulant treatmentSettore MED/15 - MALATTIE DEL SANGUEVenous thromboembolism haematological malignancythrombocytopeniaconsensuslow-molecular-weightOriginal Articlehematologic neoplasmscardiovascular diseasesvenous thrombosishumansanticoagulant treatment; blood cancer; consensus; thrombocytopenia; venous thrombosis; anticoagulants; blood platelets; heparin low-molecular-weight; humans; platelet count; consensus; hematologic neoplasms; thrombocytopenia; venous thromboembolismAnticoagulant treatment; Blood cancer; Consensus; Thrombocytopenia; Venous thrombosis
researchProduct

Vaikeiden mielenterveyshäiriöiden tarpeenmukainen hoito ja sen toteutuminen Kainuussa vuosina 2004-2005

2014

verkostoterapialäheisetpsykoositneed adapted treatmentintegrated treatmentextensive family and network centred initial examinationmielenterveystyöfamily carepatient's capacity and family burdenpsykiatrinen hoitopsyykkinen kuormittavuussevere mental health disordersmielenterveyshäiriöthoitomenetelmätverkostotyötreatment meetingcase-specific teamperhekeskeisyysKainuu
researchProduct